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Abstract 
Polymer-based electrodes for interfacing biological tissues are becoming increasingly sophisticated. 
Their many functions place them at the cross-roads of electromaterials, biomaterials, and drug-delivery 
systems. For conducting polymers, the mechanism of conductivity requires doping with anionic 
molecules such as extracellular matrix molecules, a process that distinguishes them as biomaterials and 
provides a means to control interactions at the cellular-electrode interface. However, due to their complex 
structure, directly observing the selective binding of target molecules or proteins has so far eluded 
researchers. This situation is compounded by the polymer's ability to adopt different electronic states that 
alter the polymer-dopant interactions. Here, the ability to resolve sub-molecular binding specificity 
between sulfate and carboxyl groups of dopants and heparin binding domains of human plasma 
fibronectin is demonstrated. The interaction exploits a form of biological 'charge complementarity' to 
enable specificity. When an electrical signal is applied to the polymer, the specific interaction is switched 
to a non-specific, high-affinity binding state that can be reversibly controlled using electrochemical 
processes. Both the specific and non-specific interactions are integral for controlling protein 
conformation and dynamics. These details, which represent the first direct measurement of biomolecular 
recognition between a single protein and any type of organic conductor, give new molecular insight into 
controlling cellular interactions on these polymer surfaces. 
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Polymer based electrodes for interfacing biological tissues are becoming increasingly sophisticated. Their 
many functions place them at the cross-roads of electromaterials, biomaterials and drug delivery 
systems. For conducting polymers, the mechanism of conductivity requires doping with anionic 
molecules such as extracellular matrix molecules, a process that distinguishes them as biomaterials and 
provides a means to control interactions at the cellular-electrode interface. However, due to their 
complex structure, directly observing the selective binding of target molecules or proteins has so far 
eluded researchers - this situation is compounded by the polymer’s ability to adopt different electronic 
states that alter the polymer-dopant interactions. Here, we demonstrate the ability to resolve sub-
molecular binding specificity between sulfate and carboxyl groups of dopants and heparin binding 
domains of human plasma fibronectin. The interaction exploits a form of biological ‘charge 
complementarity’ to enable specificity. When an electrical signal is applied to the polymer, the specific 
interaction is switched to a non-specific, high affinity binding state that can be reversibly controlled 
using electrochemical processes. Both the specific and non-specific interactions are integral for 
controlling protein conformation and dynamics – these details, which represent the first direct 
measurement of biomolecular recognition between a single protein and any type of organic conductor, 
give new molecular insight into controlling cellular interactions on these polymer surfaces. 
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Introduction 
Organic conducting polymers (OCP) permit conductive pathways along their conjugated backbone and are 
breaking new grounds in applications such as implantable electrodes for neural recording1 or 
stimulation2,3, tissue regenerative medicine4, 5, biosensing6, 7, and electronic cell culture systems8. They are 
easily applied as coatings on metal electrodes to increase charge storage capacity, lower impedance and 
reduce the risk of toxic electrochemical reactions9. During growth of the polymer, anionic molecules 
(dopants), which can be drugs or other biomolecules, are incorporated to counter balance charge 
generated on the polymer backbone. Electrochemical reduction of the polymer to induce charge neutrality 
initiates the release of dopants; a reversible process that is utilised in drug delivery applications10, 11. 
Alternatively, large polyelectrolyte dopants such as glycosaminoglycans (GAGs) (e.g. heparin sulfate, 
chondroitin sulfate, hyaluronic acid and dextran sulfate)  remain entrapped in the polymer and are used to 
present anchorage sites for chemical functionalization12 or bioactive groups13,14, enhance 
biocompatibility15,,or bioselectivity16, and control cellular interactions at the electrode surface17. 
Selective binding of target molecules by recognition elements (e.g. dopants) of the polymer is critical for 
biosensor, immunosensor and bioseparation applications; however non-specific binding remains an 
ongoing issue for obtaining unequivocal electrical readouts. Similarly for cell-based applications, controlling 
specific protein interactions at the polymer surface is becoming a key strategy. For example, the 
electrically-dependent conformation of proteins is thought to underlie the ability to control cell adhesion18 
and migration19. By looking at the ensemble conformation of fibronectin (FN) protein using fluorescence 
techniques, it is proposed that the proteins electrically ‘switch’ between a folded and unfold state to 
control the cell interaction20.  However, the molecular details of such protein interactions are not known 
and as yet no direct measurement for probing single protein molecule binding or conformation on an 
organic conducting polymer, or any type of organic conductor (e.g. carbon nanotube, and graphene), 
under electrical control has been demonstrated; understanding the dynamics and physics of single protein 
interactions will be a major step forward in this field of organic bioelectronics. For this reason, we 
covalently linked FN to an Atomic Force Microscope (AFM) tip and used force measurements to 
demonstrate the first direct measurement of specific protein adhesion to an organic conducting polymer, 
polypyrrole, doped with the GAGs, chondroitin sulphate (CS), hyaluronic acid (HA) and dextran sulfate (DS), 
as a function of an applied voltage. The GAG dopants can make up to 50% of the polymer composition and 
not all their anionic groups participate in charge neutralization of the polymer. For example, free sulfonate 
and carboxyl groups are anticipated to be involved in surface interactions defined by classical GAG-protein 
adhesion and recognition21, which is important for regulating cellular activities, including cell adhesion, 
extracellular matrix modelling and fibrillogenesis22.  
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Results and Discussion 
Characterization of Protein Functionalized Tip 
Human plasma fibronectin (FN) was covalently coupled to the AFM tip using a common procedure 
involving gluteraldehyde as cross-linking agent (Figure 1A and see materials and methods). Fluorescent 
images of AFM tips labelled with primary anti-fibronectin rabbit antibody before (Figure 1B, left image) and 
after (Figure 1B, right image) indicated that the functionalization procedure resulted in an FN coating on 
the chip, along the cantilever and at the tip end. Force measurements were performed after each 
functionalization step to assess the involvement of the introduced functional groups (i.e. -OH, NH3+ and 
C=O) and final coupling of the FN on the interaction between the tip and conducting polymer (Figure 1C). 
For these initial measurements, only PPy films doped with CS (PPy/CS) were assessed. Plasma treated 
silicon nitride tip (SiN3) bearing –OH groups, which are hydrophilic and negatively charged at neutral pH, 
showed no adhesion to (PPy/CS). In contrast, 3-EDSPA treated tips terminated with protonated NH3+ 
groups at neutral pH showed an electrostatic double layer force that is attractive upon approach followed 
by direct tip-surface adhesion of 2.0 ± 0.14 pN during retraction of the tip from the polymer surface. This 
attractive interaction with the positively charged tip indicates the polymer surface is negatively charged 
and further supports the presence of anionic, sulfate groups of the CS. Similarly to the plasma treated tips, 
the gluteraldehyde (GAH) functionalized tips bearing reactive carbonyl groups are hydrophilic though 
showed a small adhesion of 406 ± 35 pN with the polymer surface. The interaction of the FN functionalized 
tip showed longer range interactions, consisting of multiple adhesion peaks, that are characteristic for this 
type of protein interaction observed using AFM23, 24. These initial force measurements were thus useful in 
providing general information on the polymer surface chemistry (e.g. surface charge) and, importantly, 
confirming the FN interaction with the polymer, which is discussed in further detail below. 
 
AFM Force Spectroscopy of Fibronectin – Organic Conducing Polymer Interactions 
Figure 2A shows a schematic of the protein and chemical structures of the FN and polymer, respectively, 
and experimental setup that enables AFM force measurements of the FN-polymer/dopant interactions to 
be investigated as a function of an applied potential. During the force spectroscopy measurements, the FN-
functionalized probe is brought into contact with the polymer electrode to initiate binding and then FN-
surface adhesion forces acting on the probe are detected as it is withdrawn. Several types of FN-polymer 
interactions are detected for non-electrically stimulated polymers (Figure 2B), including no adhesion, ‘non-
specific’ FN binding, and desorption (plateau) forces. The most prevalent FN interaction (42% of force 
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curves, n = 900) is that related to the extension of the bound protein until final detachment from the 
surface (Figure 2B, top and middle force curve), which is schematically shown in Figure 2C to describe the 
corresponding interactions in the force curves. The initial part of this interaction is referred to as ‘non-
specific’ adhesion (Figure 2B and C; i) and related to bulk adhesive interactions of the FN functionalized tip 
involving inter- and intra-protein interactions and detachment of several proteins from the surface. If a 
single FN protein remains tethered between the tip and surface, force-induced unfolding of domains can 
occur (27% of force curves, n = 900) (Fig. 2B; peaks prior to and regions ii and iii) (Figure 2C; ii and iii) and is 
identified by successive rupture peaks with spacings of 13.1 ± 0.4 nm (mean ± s.e.m., n = 137) and 28.8 ± 
0.7 nm (mean ± s.e.m., n = 107) correlated to the length of unfolded intermediates or FNIII domains23, 25, 26, 
respectively (Figure 2D). Forces of 147.1 ± 8.6 pN (mean ± s.e.m., pulling-rate 500 nm/sec, n = 198) 
required for domain unfolding are also characteristic of single molecule FN interactions. Successive rupture 
peaks also occur due to detachment of multiple FN–polymer binding sites wherein the first binding site 
detaches (Figure 2B; peak prior to region iv) (Figure 2C iv), followed by extension of the protein (Figure 2B; 
iv), until detachment of the second and final binding site (Figure 2B and C; final peak). These binding events 
can occur in the absence of domain unfolding (Figure 2B; v) and have peak spacings of 58.9 ± 3.0 nm (mean 
± s.e.m., n = 67) (Figure 2D), which are greater than the lengths of unfolded FN domains and therefore 
distinguish detachment of the protein from the surface. This peak spacing of 58.9 ± 3.0 nm also suggests 
that binding is most probable at sites on the protein separated by this distance or, alternately, the 
existence of specific binding sites on the protein. The detachment of the protein can also proceed less 
commonly via ‘non-specific’ desorption forces that show a constant force independent of the extension 
length, i.e. plateau forces (Figure 2B; vi in bottom curve). Plateau forces are commonly observed for 
polyelectrolyte chain desorption from a surface, much like a polymer chain being ‘peeled’ off the surface, 
and arise due to dependencies on the dissociation rate of repeating polymer chain-surface contacts 
relative to the extension rate27 and presence of an oppositely charged surface28.  
 
To elucidate interactions involving detachment (or effective binding) sites of the protein, we focused on 
analysing individual force profiles representing the unfolding and/or extension of FN, as described above in 
Figure 2B (top and middle curves). More specifically, the analysis involved subtracting the distances of all 
peak spacings, including those associated with unfolding and protein–surface detachment, from the 
distance at the final peak. This gives what we refer to as the “corrected binding distance” (CBD), 
representing the extended length of the FN, tethered between the tip and surface, just prior to undergoing 
domain unfolding and/or surface detachment (Figure 2C; far right schematic). The CBD is thus governed by 
the distance between the two attachment positions (dashed lines) of the protein to the tip and polymer; 
Page 6 of 21 
 
this being firstly, the covalent attachment of the protein to the probe and secondly, the non-covalent 
protein-surface binding site that is either the first of multiple binding sites to detach, as shown in Figure 
2C, or the sole (and final point of detachment) when no other binding sites are present.   
 
Probability density functions of the CBD show a primary peak distribution value ranging from 59 - 66 nm 
for all polymers, with a secondary peak distribution value ranging from 116 – 119 nm for CS and DS 
polymers and possibly PTS and HA (Figure 3A). Minor peak CBD distribution values also appear at 171 nm 
and 166 nm for CS and PTS, respectively (Figure 3A). The significance of these CBD distributions is that, 
even though FN binding to the tip is generally expected to be random via gluteraldehyde linkages with 
nucleophilic amine groups at the N-terminus and on free lysine residues, their observation indicates that 
both the tip and polymer must bind to specific sites on the FN.  Furthermore, the presence of CBD values at 
166-171 nm corresponds to the length of ≈ 160-175 nm for fully stretched plasma FN29, F30, 31. To obtain 
these values, it would require that the FN be attached to an N-terminus and interact with the polymer via 
the opposing N-terminus. This binding configuration, which presumably allows the entirety of the 
extended FN molecule to freely interact, is likely to facilitate binding at additional sites separated by the 
distance of 58.9 ± 3.0 nm (mean ± s.e.m., n = 67) previously observed in the rupture spacings (Figure 2D). 
Repeated sampling of the 3 different peak CBD distribution values within sets of force curves (n = 25) from 
individual AFM tip experiments (n = 36) further supports the detection of multiple binding sites along a 
single FN molecule instead of multiple interacting FN molecules having 3 different specific binding 
configurations and each with an extended length differing by ≈ 60 nm. These observations suggest that FN 
preferentially has a fixed attachment to the tip in the vicinity of an N-terminus with binding occurring at 
specific sites along its length. 
 
Based on the above observations, we use the known FN structure and dimensions of the FNI, FNII, FNIII 
domains based on X-ray crystallography studies32 to construct coordinate map for identifying positions on 
the protein involved in binding to the polymer (Figure 3B). The map gives a calculated FN length of 158.8 
nm by taking into account the size of each individual domain and absence of variable splicing regions for 
plasma FN. The preferred N-terminus binding position of the tip is made the zero reference point in order 
to identify the binding locations. The extent of net positive charge of each FN domain33, which generally 
underlies their binding affinity to sulfate sites on GAGs34, is also specified. When cross-referencing the 
peak distribution values of the CBD (black asterix) to their locations on the model, we observe that they 
superimpose to well-known Heparin (Hep) binding domains (Figure 3B; black highlighted domains), 
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including a particular sequence of the HepII FNIII12-14 near the COOH-terminus, HepIII FNIII4-6 and HepI FNI1-
5. Interestingly, the compact conformation of FN is stabilized by intermolecular bonds at the positions of 
these three domains35 but can be disrupted by interacting surface groups, particularly hydrophilic and 
negatively charged surfaces, causing the protein to adopt a more unfolded conformation36,37. We suggest 
that the binding of this particular sequence of Hep domains is presumably facilitated by their close 
association and thus collective presentation to the polymer surface during the force spectroscopy 
measurements. The main CBD distribution at 59-66 nm indicates most probable binding occurs at the HepII 
domain and accordingly this is recognized as the highest affinity GAG binding site due to the presence of 
discontinuous positively charged amino acids in FNIII13-14 domains that form a cationic cradle38. Standard 
deviations of the CBD distributions associated with the HepII domain reflect the binding specificity at this 
position (Figure 3B; horizontal arrows above HepII region), which is highest for CS followed by DS and then 
HA and PTS. A higher affinity and/or specificity of binding for CS is also evident in single molecule FN-
polymer unbinding forces that are significantly higher for CS (164 ± 10.1 pN, n = 61) compared to DS (115 ± 
11.0 pN, n = 41), HA (108 ± 8.5 pN, n = 30) and PTS (124 ± 12.5 pN, n = 66) (Fig. 3C). Along with heparin, CS 
is a main competitor in FN binding with important binding determinants located to the HepII FNIII13-14 
domains39.  Heparin-FN interactions have been mimicked using synthetic polysaccharides like DS40, while 
for the non-sulfated HA it is uncertain if binding on its own is possible or requires the presence of 
mediating proteoglycans41. Many of these early studies involve binding of FN fragments whereas our 
approach using intact FN shows that all polymers, including those with HA, are capable of specific binding. 
Even for small molecular weight PTS bearing a single sulfate group per molecule, its distribution at the 
polymer surface is sufficient to enable specific binding of the HepII domain.  
 
Effect of Electrical Stimulation on Fibronectin Binding  
In contrast to measurements on gold electrodes that show no adhesion dependence on the applied 
potential (Figure 4A), FN adhesion on the polymers significantly increases by ≈ 5 – 10 times at positive 
potentials and then decreases as the applied potential is reversed (Figure 4B). This is highlighted in force 
profiles of the gold electrode (Figure 4A) and CS doped polymer (Figure 4B) acquired at applied potentials 
of +0.4 V, 0 V and -0.4 V during the cyclic voltammograms. The reversibility of adhesion during cycling of 
the potential between +0.4 V  and -0.4 V is conveyed in graphs that are analogous to cyclic voltammograms 
(solid grey curve) but plot the maximum adhesion force (black dashed curve) as a function of voltage 
(Figure 5). Combining force and cyclic voltammetry measurements has recently been demonstrated for 
DNA interactions on gold electrodes and referred to as ‘Roburograms’ (Robur is the Latin for ‘force’)42.  All 
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the polymers showed a similar response, in particular, a dramatic reversible adhesion between 0.2-0.4 V at 
scan rates of 50 mV/sec. Although the interaction of multiple FN molecules is likely, the increase in 
adhesion does not scale with (n) possible number of interacting proteins given that a single compact FN 
molecule of ≈ 20 * 15 nm is comparable to the interaction area of the probe. Compared to the gold, the 
polymer electrode micro- and nanotopography and porosity significantly increase the charge storage 
capacity, as evidenced by a significant increase in the area of the cyclic voltammograms (Figure 5, c.f. gold 
and polymer). A related increase in surface charge density is most likely responsible for a strong columbic 
attraction with the majority of negatively charged FN domains that effectively “pins-down” the protein. 
Furthermore, the outward diffusion of charge balancing cations occupying anionic sites on the dopant 
during the applied potential is rate limiting. This renders the anionic sites unavailable for neutralization of 
positive charges generated on the polymer backbone – thus giving rise to a high positive surface charge 
density. When cycling at slower scan rates of 5mV/sec, as demonstrated for CS doped polymers, the ion 
diffusion is conversely not rate-limited and charge neutralization of the polymer can proceed to negate 
attraction of the FN (Figure 5). 
 
Molecular Switching of Fibronectin Binding & Conformation via Electrochemical Control 
Based on the above picture emerging of the FN interactions, we propose a model that provides molecular 
insight into the switching mechanisms of single molecule FN-conducting polymer interactions, particularly 
as the protein alters binding affinity and conformation in response to equilibrium and non-equilibrium 
redox states of the polymer under electrical control (Figure 6). The involvement of heparin domains in 
binding to the non-electrically stimulated polymers is explained by a ‘bio-specific’ interaction whereby 
cationic sites of the protein and anionic sites of the dopant undergo charge polarization at small separation 
distances (Figure 6A). The implication for the subsequent formation of discrete bonds at heparin domains, 
coupled to the flexibility of the protein’s extended conformation, is that local structural changes are 
induced to actively present cell binding (RGD) domains43. This binding configuration can be 
electrochemically switched to induce non-specific binding (Figure 6B); a reversible process that is expected 
to significantly alter the protein conformation. Oxidation of the polymer results in a dramatic increase in 
binding strength; however the flexibility of the protein is diminished (Figure 6B). During reduction of the 
polymer, the polymer backbone is uncharged and the protein is presumably able to interact with free 
anionic groups in a similar manner to the non-stimulated polymer (Figure 6C).  While others have focused 
on the FN conformation18, 19, 20, our study uniquely quantifies the FN-polymer interfacial forces that play a 
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critical role in force-dependent signal transduction processes such as cellular forces exerted on FN through 
integrins to regulate cell adhesion and migration. 
Conclusions 
 The study demonstrates a new approach by using AFM to directly measure biomolecular recognition of 
single molecules under electrical control that is also valuable in its application to other organic conductors 
(e.g. graphene and carbon nanotubes), semiconductors and metals. The approach will be of significant 
interest in the areas of the cell-electromaterial interface, organic bioelectronics, electrophysiology and 
implantable electrodes (e.g. cochlear implant), particularly as researchers endeavour to fabricate organic 
electrodes that make better electrical ‘connections’ to living cells and tissues. It opens up the possibility of 
assessing a range of other biomolecules (e.g. growth factors) whose redox-controlled surface binding and 
subsequent release is implicated as an important strategy for temporally controlling nerve, muscle and 
stem cell growth and survival. It is also likely to burgeon in the immense field of electrically-based 
biosensing that is heavily reliant upon biomolecular recognition at electrodes.  
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Methods: 
The pyrrole monomer was obtained from Merck and distilled prior to use. The chemicals used as the 
dopants were the sodium salts of para-toluenesulfonic acid (pTS), hyaluronic acid (HA), dextran sulfate (DS) 
and chondroitin sulfate A (CS). CS and DS were obtained from Sigma, pTS from Merck and HA from Fluka. 
All solutions were prepared with deionised Milli-Q water (18.2MΩ).  Gold coated mylar was firstly prepared 
by cutting into strips of 0.5 cm by 2 cm area and then cleaned with methanol and Milli-Q water. An 
aqueous monomer solution of 0.2 M pyrrole and 2 mg/mL of the counter-ion dopant was degassed in N2 
for 10 min prior to polymerisation of the polymers. Polypyrrole (PPy) films were grown galvanostatically at 
a current density of 0.25 mA/cm2 for 10 min in the aqueous monomer solution using an eDAQ EA161 
potentiostat and recorder to monitor the polymerization charge. Polymer growth was performed in a 
standard 3-electrode electrochemical cell with the gold coated mylar as the working electrode, a platinum 
mesh counter electrode and Ag/AgCl reference electrode. After growth, the films were washed with Milli-Q 
water, gently dried with N2 gas and placed in petri dishes until use. 
The functionalization chemicals 3-ethoxydimethylsilylamine propyl (3-EDSPA) and gluteraldehyde 
(GAH) were obtained from Sigma Aldrich. Human plasma fibronectin (FN) was obtained from Sigma 
Aldrich. Phosphate buffer saline (PBS) was prepared at pH 7 in Milli-Q water (18.2MΩ). The tip is 
functionalized using an aminosilzation method to covalently bind the protein to the tip. Silicon nitride tips 
are used for this method due to the availability of silicon oxide groups on the surface. The tips were initially 
cleaned with a plasma cleaner to remove any impurities or functionalized groups on the surface. Once 
cleaned the tips were immediately functionalized to minimise contaminants on the surface.  The tips were 
placed into the EDSPA solution at room temperature for 1 h. The tips were then removed, washed 
consecutively with toluene, then PBS solution. The tips were then immersed in the GAH solution for 1 h, 
and then rinsed with PBS solution. The tips were finally immersed in the FN solution for 1 h, then rinsed 
and refrigerated in PBS solution until use.  To visualize functionalization of the tips, FN functionalized AFM 
probes were prepared for antibody binding using Alexa488 goat anti-rabbit IgG (Invitrogen) and primary 
anti-fibronectin rabbit antibody (ICN Biomedicals Inc). The tips were blocked in PBS with 10% donkey 
serum at room temperature for 1 hr then incubated in primary anti-fibronectin (rabbit) antibody in PBS 
with 10% donkey serum at 37 °C. The tips were rinsed twice in PBS, then incubated in a secondary antibody 
(Alexa488 goat anti-rabbit IgG) in PBS with 10% donkey serum. The tips were then rinsed twice with PBS 
and imaging using the Zeiss Axio Epifluorence microscope. 
Electrochemical–AFM (EC-AFM) was implemented by positioning a 2-dimensional electrochemical 
cell on the sample stage of an MFP-3D Asylum Research AFM (Santa Barbara, CA). The electrochemical cell 
was made out of a Teflon block that consisted of a u-shaped fluid well etched around a platform. A PPy 
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polymer film was glued onto the platform and acted as the working electrode. A platinum mesh counter 
electrode was positioned in the fluid well and a silver wire pseudo-reference electrode was placed 
alongside the polymer film. Electrochemical measurements were controlled using an eDAQ EA161 
potentiostat/recorder and carried out in PBS buffer solution, which was injected into the fluid well to 
immerse the three electrodes. Force spectroscopy measurements were firstly performed on non-
electrically stimulated films with PBS as the electrolyte. 5 consecutive force curves were collected at one x-
y position with a total of 5 different positions across the film being sampled. This was repeated using 3 
different functionalized tips on the same film. For each of the differently doped films (i.e. CS, DS, HA, PTS), 
a total of 3 film samples were measured. Force curve parameters included a 500 nm ramp distance, 0.5 Hz 
scan rate, 1 sec dwell time at the surface and trigger force of 1nN. Force curves were then acquired during 
electrical stimulation of the films under the EC-AFM. Polymer films were electrically stimulated by applying 
cyclic voltammetry from -400 to +400 mV with either scan rates of 50mV/sec or 5mV/sec for 5 cycles. The 
z-piezo and deflection signal were outputted to the eDAQ EA161 potentiostat/recorder and recorded 
simultaneously with the current and voltage. Analysis of the force curves were carried out using the 


















Figure 1. A) Schematic of procedure for protein functionalization of AFM tip. B) Fluorescence image of 
fluorescently labelled AFM tip before (left image) and after (right image) protein functionalization. C) AFM 
force curves performed on PPy/CS after each functionalization step, including plasma treatment (SiN3), 
amino-salinization (3-EDSPA), gluteraldehyde treatment (GAH) and final coupling of the protein (FN).         
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Figure 2. A) Schematic diagram of AFM tip functionalized with FN interacting with a conducting polymer 
electrode (blue), polypyrrole (PPy), comprising a conjugated backbone (black chemical structure) with 
entrapped dopants (green) such as chondroitin sulphate (CS), hyaluronic acid (HA) or dextran sulfate (DS). 
FN is a protein dimer comprising two identical monomers linker by a pair of C-terminal disulfide bonds. 
Each monomer contains three types of repeating domains, types FNI (orange rectangle), FNII (blue 
diamond), FNIII (red ovals) and an N-terminal. Force spectroscopy measurements were performed as a 
function of an applied voltage using electrochemical–AFM. The PPy-electrode operated as the working 
electrode in 3-electrode electrochemical cell, including auxiliary and reference electrodes, positioned 
under the AFM. B) AFM force curves for the interaction of FN with non-electrically stimulated PPy/CS 
showing the trace (orange) and retrace (blue) curves. The peak at (i) corresponds to initial detachment of 
the tip and fibronectin molecules from the surface. The two subsequent peaks (1st and 2nd dashed lines) 
and their spacing of 27.1 nm (ii) and 28.5 nm (iii) correspond to the sequential unfolding of FNIII modules 
(~ 75 amino acid residues). A peak spacing of 47.8 nm at point (iv) is greater than that for FN unfolding and 
correlates with multiple detachment of FN-polymer binding sites. The first binding site detaches (3rd 
dashed line) followed by extension of the protein until the second and final site detaches (4th dashed line). 
Such binding events can occur in the absence of domain unfolding (point v in bottom curve).  C) 
Corresponding schematic depicting the different interactions in top curve in (A). (i) non-specific adhesion 
peak; (ii) unfolding of 1st domain (red circle); (iii) unfolding of 2nd domain (red circle); (iv) detachment of 1st 
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FN-polymer binding site (green triangle);  (final peak) detachment of 2nd and final FN-polymer binding site 
(green triangle). For analysis of the corrected binding distance (CBD), the “added” distances gained during 
extension of the protein (i.e. peak spacings due to unfolding/multiple detachment sites) are subtracted 
from the final peak distance. The CBD (vertical arrow) therefore represents the extended length of the FN 
prior to unfolding or surface detachment and is effectively the same situation as that depicted prior to (ii).  
D) Probability density functions of distances between successive rupture peaks in force profiles from all 
polymers. Red curves are individual gaussian fits and automated multipeak fitting (blue curves) (IGOR PRO, 
Wavemetrics). Peak distributions at 13.1 ± 0.4 nm (mean ± s.e.m., n = 137) and 28.8 ± 0.7 nm (mean ± 
s.e.m., n = 107) have previously been attributed to intermediate and fully unfolded lengths of FNIII 
domains, respectively.  Higher peak value distributions at 58.9 ± 3.0 nm (mean ± s.e.m., n = 67) correspond 
to distances between multiple protein-polymer binding sites. 
 
Figure 3. A) Probability density functions of corrected binding distance (CBD) for CS (n = 121), DS (n = 77), 
HA (n = 65), PTS (n = 112) doped polymers. Light grey curves are individual gaussian fits and automated 
multipeak fitting (solid dark curves) (IGOR PRO, Wavemetrics). The peak CBD distribution values labelled in 
blue are: (CS) 59.0 ± 9.3 nm (mean ± s.d., n = 70), 116.0 ± 11.7 nm (mean ± s.d., n = 27), 171.0 ± 6.6 nm 
(mean ± s.d., n = 13); (DS) 64.3 ± 13.6 nm (mean ± s.d., n = 51), 116.7 ± 3.8 nm (mean ± s.d., n = 16); (HA) 
65.5 ± 18.0 nm (mean ± s.d., n = 38), 119.1 ± 6.3 nm (mean ± s.d., n = 20); (PTS) 59.9 ± 14.4 nm (mean ± 
s.d., n = 69), 116.0 ± 8.5 nm (mean ± s.d., n = 22), 166.0 ± 8.6 nm (mean ± s.d., n = 14). B) Model of 
extended FN showing calculated length of 158.8 nm based on x-ray crystallography dimension of FNI (2.5 
nm, rectangles), FNII (0.7 nm, diamonds) and FNIII (3.2 nm, ovals), where 0 nm corresponds to the 
attachment position of FN to the AFM tip. The heparin binding domains, HepIIFN12-14 (position = 59.1 – 68.7 
nm), HepIIIFN4-6 (position = 115.7– 125.3 nm) and HepIFN1-5 (position = 143.2– 158.8 nm) are coloured in 
black. The peak CBD distribution values labelled in (A) and listed above are marked at their respective 
positions on the protein with a black asterix. Standard deviations calculated from the full width half 
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maximum (FWHM) (where FWHM = 2 √2ln2σ) of peak CBD distribution values of the HepIIFN12-14 domain 
for each dopant are given by the length of the horizontal arrows.  C) Single molecule FN-polymer unbinding 
forces for each polymer. The values are taken from the force value of the final peak (detachment of the 
polymer) and represent the primary peak distribution of probability density functions.  
 
Figure 4.  Representative force curves for (A) gold electrode and (B) PPY/CS polymer taken at 400 mV, 0 
mV  and -400 mV from a cyclic voltammogram with a scan rate of 50mV/sec.  
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Figure 5. Maximum adhesion force (black dashed curve) versus voltage and corresponding cyclic 
voltammograms (solid grey curve) for the gold electrode and PPy polymer films doped with CS, DS, HA and 
pTS. The adhesion force values (black circles) represent an average from individual force curves collected 
at each time point during 3 CV cycles performed at a scan rate of 50mV/sec. The bottom right graph is the 
same measurement performed for the PPy/CS CS polymer at a slower scan rate of 5 mV/sec.    
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Figure 6. A) Non-Electrically Stimulated Polymer: The model translates the AFM observations to the 
expected binding interaction of a single FN molecule (only one FN monomer is shown) given the 
involvement of multiple heparin domains (blue domains). The ability of multiple binding via the different 
heparin domains indicates that the FN is more likely to adopt an extended conformation, which is depicted 
in the model based on previous representations of unfolded FN adsorbed onto negatively charged 
surfaces44. This configuration is considered to be more bioactive due to the presentation of RGD regions.  
Because FN is an amphoteric protein, repulsion of the predominately negatively charged protein with 
sulfate or carboxyl groups (green charges) of the GAGs can revert to attractive forces due to preferential 
alignment of the cationic heparin domains (blue highlighted). When the protein is at a very small 
separation distance from the polymer, the charges interact as discrete entities rather than part of an 
overall net charge and subsequent columbic attraction of individual ion pairs governs the protein-surface 
binding, as opposed to the net protein interaction. This type of bio-specific interaction is referred to as 
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“charge complementarity”45.  B) Electrically Stimulated Polymer: The application of a positive voltage 
induces charge (black positive charge) on the polymer backbone causes a strong columbic attraction of the 
negatively charged FN domains.  At higher scan rates (50 mV/sec), outward diffusion of charge balancing 
cations (C+) occupying anionic sites on the immobile GAGs is rate limiting. This renders anionic sites on the 
dopant unavailable for charge neutralization of the positive charges on the polymer and protein adhesion 
is present. At lower scan rates (5mV/sec), outward cation diffusion (black arrows) is not rate-limited and 
charge neutralization of the polymer proceeds to decrease protein adhesion. C) During the application of 
negative potentials, the polymer backbone is uncharged and free sulfate or carboxyl groups are expected 
to similarly interact with the protein, as described above in (A). The mechanism is reversible (red arrow) 
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